Literature DB >> 12233807

Leech therapy for symptomatic treatment of knee osteoarthritis: results and implications of a pilot study.

Andreas Michalsen1, Susanne Moebus, Günther Spahn, Tobias Esch, Jost Langhorst, Gustav J Dobos.   

Abstract

CONTEXT: Leech therapy was a mainstay in conventional treatment for pain from antiquity until the mid-19th century. Its use is still widespread in traditional healing procedures in Asia, Africa, and Arabic countries. There is renewed interest in leech therapy in the field of complementary medicine and empirical evidence for specific benefit in knee osteoarthritis.
OBJECTIVES: To determine the effect of leech therapy as an adjunctive treatment in painful knee osteoarthritis, to investigate the onset of action, to evaluate patients' acceptance of this treatment, and to investigate the side effects of the procedure.
DESIGN: Observational, controlled, nonrandomized pilot-study.
SETTING: Subjects were inpatients of an academic teaching hospital of the University of Essen, Department of Internal and Integrative Medicine, Essen, Germany. PATIENTS: 16 inpatients (mean age 69 +/- 9 years) with a confirmed diagnosis of osteoarthritis of the knee joint; 10 patients were treated with leeches and 6 served as controls. INTERVENTION: A single trial of 4 leeches (Hirudo medicinalis) applied topically at painful periarticular sites of the knee joint in the experimental group (n = 10). Both groups received conventional treatment for pain with the exclusion of nonsteroidal anti-inflammatory drugs. MAIN OUTCOME MEASURES: Self-reported general knee pain, assessed by visual analog scale for 10 days daily and in a follow-up after 28 days. Frequency of adverse effects also was recorded.
RESULTS: Periarticular application of 4 leeches led to rapid relief of pain with sustained improvement after 4 weeks in the absence of major complications.
CONCLUSION: Leech therapy may be an effective treatment for rapid reduction of pain associated with osteoarthritis of the knee. Its efficacy should be tested in larger randomized controlled trials with assessment of expectation bias.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12233807

Source DB:  PubMed          Journal:  Altern Ther Health Med        ISSN: 1078-6791            Impact factor:   1.305


  8 in total

Review 1.  Osteoarthritis: understanding the pathophysiology, genetics, and treatments.

Authors:  Vladamir Sinkov; Tyler Cymet
Journal:  J Natl Med Assoc       Date:  2003-06       Impact factor: 1.798

2.  Medicinal leech therapy and Aeromonas spp. infection.

Authors:  B Verriere; B Sabatier; E Carbonnelle; J L Mainardi; P Prognon; I Whitaker; L Lantieri; M Hivelin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-04-02       Impact factor: 3.267

Review 3.  Medicinal leech therapy in pain syndromes: a narrative review.

Authors:  Detlev Koeppen; Michael Aurich; Thomas Rampp
Journal:  Wien Med Wochenschr       Date:  2013-10-01

4.  The efficacy and safety of the Shaoyao Shujin tablet for knee osteoarthritis: study protocol for a randomized controlled trial.

Authors:  Xue-Wei Cao; Da Guo; Jin-Wen Liu; Wei Niu; Jun Liu; Jian-Ke Pan; Hui Xie; Wen-Wei Ouyang; Ding-Kun Lin
Journal:  Trials       Date:  2016-01-04       Impact factor: 2.279

Review 5.  Management strategies for Janu Sandhigata Vata vis-a-vis osteoartheritis of knee: A narrative review.

Authors:  Ahalya Sharma; T V Shalini; S J Sriranjini; B A Venkatesh
Journal:  Ayu       Date:  2016 Jan-Mar

Review 6.  European Medicinal Leeches-New Roles in Modern Medicine.

Authors:  Sarah Lemke; Andreas Vilcinskas
Journal:  Biomedicines       Date:  2020-04-27

7.  Leech therapy for epidermoid cysts and review of the literature.

Authors:  Abbas Rasi; Alireza Faghihi; Mirhadi Aziz Jalali; Abbas Zamanian; Gholamhossein Ghaffarpour
Journal:  Adv Biomed Res       Date:  2014-03-31

8.  Experimental Investigation on the Morphology and Adhesion Mechanism of Leech Posterior Suckers.

Authors:  Huashan Feng; Ningli Chai; Wenhao Dong
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.